Bevacizumab biosimilar(Laboratorios Sophia)
贝伐珠单抗生物类似药（Laboratorios Sophia）
Report date: 2026/03/17 20:00:15
Base Information
Drug NameBevacizumab biosimilar(Laboratorios Sophia)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Sophia Sa De Cv
China Registration ClassN/A
Develop Information
Active CompaniesLaboratorios Sophia Sa De Cv
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A